Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Mindfulness Group Therapy for Young People Hospitalized With Early Psychosis

Tests mindfulness-based group sessions added to usual care in young inpatients with early psychosis.

Plain-language title generated from the registry record
Registry title: FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

Key facts

Where
Augsburg, Berlin, Cologne, Hamburg, Mannheim, Marburg, and München, GermanySee the 8 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 16 to 35 who are in hospital or a day clinic with an early psychosis. It tests a mindfulness-based group therapy.

Age
16 to 35 years
Sex
All sexes can join.
Disease stage
Early psychosis: a first psychotic episode within the last 5 years, confirmed as a schizophrenia spectrum or other psychotic disorder.
Earlier treatment
The person must be getting inpatient or day clinic treatment, with a planned stay of at least 4 weeks.

Main reasons for not taking part

  • Not enough German language skills
  • Acute suicidality
  • Acute threat to others

Read by machine on 9 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 35 years old?

Source: NCT07645443, who can take part

Where in Germany

  • University of Augsburg, Department of Psychiatry and Psychotherapy, Geschwister-Schoenert-Str. 1, 86156 AugsburgAugsburg, GermanyContact: Benjamin Pross, Dr.Taking people
  • Charité-Universitätsmedizin Berlin (CCM), Department of Psychiatry and Psychotherapy, , Charitéplatz 1, D-10117 Berlin, GermanyBerlin, GermanyContact: Kerem Böge, Prof. Dr. DrTaking people
  • Vivantes Klinikum am Urban, Hospital for Psychiatry, Psychotherapy und Psychosomatics, Dieffenbachstr. 1, 10967 BerlinBerlin, GermanyContact: Andreas Bechdolf, Prof. Dr.Taking people
  • University of Cologne, Department of Psychiatry and Psychotherapy, Kerpener Str. 62, 50937 CologneCologne, GermanyContact: Paula MengelkampTaking people
  • University of Hamburg, Universitätsklinikum Hamburg-Eppendorf Hamburg, Department of Psychiatry and PsychotherapyHamburg, GermanyContact: Schirin GellertTaking people
  • University of Mannheim, Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, J5, 68169 MannheimMannheim, GermanyContact: Lana WölflTaking people
  • Marburg University, Department of Psychiatry and Psychotherapy, Rudolf-Bultmann-Str. 8, 35039 Marburg, GermanyMarburg, GermanyContact: Mara BachNo longer taking part
  • Ludwig-Maximilians Universität Munich, Department of Psychiatry and Psychotherapy, Nussbaumstr. 7, 80336 MunichMünchen, GermanyContact: Simone Sachenbacher, Dr.Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Stephanie Mehl
Trial code
NCT07645443
Record updated
22 September 2026
Original description
FEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early psychosis. Participants are randomized 1:1 to FEEL-GOOD plus treatment as usual (TAU) or TAU alone. The intervention consists of one individual preparatory session and eight modularized group sessions delivered over four weeks involving four to eight participants at each session and including practice and homework tasks. Outcomes are assessed at baseline, 4 weeks post-intervention, and 6 months follow-up, with the primary outcome being observer-rated total psychopathology as measured with the assessed by the total score of the Positive and Negative Syndrome Scale (PANSS) post-treatment (4 weeks post baseline).Read full original descriptionShow less

Mindfulness-based Group Therapy in Young Inpatients With Acute Early Psychosis (FEEL-GOOD)

FEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early psychosis. Participants are randomized 1:1 to FEEL-GOOD plus treatment as usual (TAU) or TAU alone. The intervention consists of one individual preparatory session and eight modularized group sessions delivered over four weeks involving four to eight participants at each session and including practice and homework tasks. Outcomes are assessed at baseline, 4 weeks post-intervention, and 6 months follow-up, with the primary outcome being observer-rated total psychopathology as measured with the assessed by the total score of the Positive and Negative Syndrome Scale (PANSS) post-treatment (4 weeks post baseline).

Inclusion: Age 16 to 35 years; Clinical diagnosis of early psychosis, defined as first psychotic episode within the last 5 years as assessed with the Structural Clinical Interview for DSM-5 Research Version (SCID-5-RV); DSM-5 schizophrenia spectrum or other psychotic disorder confirmed with SCID-5-RV (DSM-5: 297.1, 298.8, 295.4, 295.9, 295.7, 298.8, 298.9) Currently receiving inpatient/day clinic treatment with a planned stay of at least 4 weeks; Interested in and willing to participate in FEEL-GOOD and/or TAU.

Exclusion: Insufficient German language abilities; Acute suicidality or acute threat to others.

ClinicalTrials.gov NCT07645443